Literature DB >> 21442661

Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.

Richard Camicioli1, Jennifer Sabino, Myrlene Gee, Thomas Bouchard, Nancy Fisher, Chris Hanstock, Derek Emery, W R Wayne Martin.   

Abstract

Age-related ventricular enlargement is accelerated in Alzheimer's disease, but its relationship to cognitive decline in Parkinson's disease is less clear, even though dementia is common in Parkinson's disease. Our goals were to determine if greater enlargement of the ventricles and gray or white matter atrophy occurred in Parkinson's disease patients developing cognitive decline. Older nondemented patients with Parkinson's disease (33) and age- and sex-matched controls (39) were recruited and prospectively assessed for the development of significant cognitive decline over 36 months. Magnetic resonance imaging was obtained every 18 months, and ventricular volume and total brain gray and white matter volumes were measured using reliable segmentation of T1-weighted volumetric scans. Subjects with incidental intracranial abnormalities, an atypical course, and stroke as well as dropouts were excluded from a cohort of 52 patients and 50 controls. Among 33 patients and 39 controls, 10 patients and 3 controls developed significant cognitive impairment or dementia. Ventricular change and Parkinson's disease status were significantly associated with dementia. Ventricular change was significantly correlated with change in Mini-Mental Status Examination in the Parkinson's disease with dementia group (r = 0.87, P = .001). Gray matter atrophy was greater in Parkinson's disease with dementia, with similar change over time in both Parkinson's disease and Parkinson's disease with dementia. White matter volumes were not significantly different between Parkinson's disease and Parkinson's disease with dementia; however, the decrease over time might be greater in Parkinson's disease with dementia. Ventricular dilatation occurs early in the course of significant cognitive decline in patients with Parkinson's disease, possibly reflecting both cortical gray and white matter loss.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21442661     DOI: 10.1002/mds.23700

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

1.  Neurocognitive speed and inconsistency in Parkinson's disease with and without incipient dementia: an 18-month prospective cohort study.

Authors:  Cindy M de Frias; Roger A Dixon; Richard Camicioli
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

2.  An update on brain imaging in parkinsonian dementia.

Authors:  Myria Petrou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Imaging Med       Date:  2012-04

3.  The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions.

Authors:  Mechelle M Lewis; Guangwei Du; Eun-Young Lee; Zeinab Nasralah; Nicholas W Sterling; Lijun Zhang; Daymond Wagner; Lan Kong; Alexander I Tröster; Martin Styner; Paul J Eslinger; Richard B Mailman; Xuemei Huang
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

4.  Longitudinal white matter microstructural change in Parkinson's disease.

Authors:  Vincent Pozorski; Jennifer M Oh; Nagesh Adluru; Andrew P Merluzzi; Frances Theisen; Ozioma Okonkwo; Amy Barzgari; Stephanie Krislov; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Andrew L Alexander; Catherine L Gallagher
Journal:  Hum Brain Mapp       Date:  2018-06-27       Impact factor: 5.038

5.  Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment.

Authors:  Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

Review 6.  Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies.

Authors:  Ping Lei Pan; Hai Cun Shi; Jian Guo Zhong; Pei Rong Xiao; Yuan Shen; Li Juan Wu; Yuan Ying Song; Gui Xiang He; Hua Liang Li
Journal:  Neurol Sci       Date:  2012-11-27       Impact factor: 3.307

7.  Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment.

Authors:  Carlo Tessa; Claudio Lucetti; Marco Giannelli; Stefano Diciotti; Michele Poletti; Sabrina Danti; Filippo Baldacci; Claudio Vignali; Ubaldo Bonuccelli; Mario Mascalchi; Nicola Toschi
Journal:  Hum Brain Mapp       Date:  2014-01-22       Impact factor: 5.038

8.  Evolution of deep gray matter volume across the human lifespan.

Authors:  Karl Narvacan; Sarah Treit; Richard Camicioli; Wayne Martin; Christian Beaulieu
Journal:  Hum Brain Mapp       Date:  2017-05-26       Impact factor: 5.038

9.  The Value of Shunt Surgery or Prophylactic Antiepileptic Therapy or Both in the Development of Dementia at Early Stages in Patients With Ventricular Dilatation.

Authors:  Konstantinos Faropoulos; Ourania Fotakopoulou; George Fotakopoulos
Journal:  Cureus       Date:  2022-05-28

10.  Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.

Authors:  Wei Han; Shraddha Sapkota; Richard Camicioli; Roger A Dixon; Liang Li
Journal:  Mov Disord       Date:  2017-09-07       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.